salmeterol xinafoate has been researched along with Allergic Reaction in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bender, BG | 1 |
| Jansen, HM; Koopmans, JG; Lutter, R; van der Zee, JS | 1 |
| Aaronson, DW | 1 |
| Chipps, B | 1 |
| Brogden, RN; Faulds, D | 1 |
| Butchers, PR; Johnson, M; Vardey, CJ | 1 |
2 review(s) available for salmeterol xinafoate and Allergic Reaction
| Article | Year |
|---|---|
Where does health communication technology fit into allergy practice?
Topics: Anti-Allergic Agents; Biosensing Techniques; Confidentiality; Exhalation; Fluticasone; Health Communication; Humans; Hypersensitivity; Medical Informatics; Monitoring, Physiologic; Nitric Oxide; Patient Compliance; Salmeterol Xinafoate; Self-Management; Smartphone; Spirometry | 2018 |
Salmeterol xinafoate. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Animals; Asthma; Bronchoconstriction; Humans; Hypersensitivity; Salmeterol Xinafoate | 1991 |
2 trial(s) available for salmeterol xinafoate and Allergic Reaction
| Article | Year |
|---|---|
Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils.
Topics: Administration, Inhalation; Albuterol; Allergens; Androstadienes; Asthma; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Eosinophils; Fluticasone; Humans; Hypersensitivity; Interleukin-5; Leukocyte Count; Salmeterol Xinafoate; Time Factors | 2005 |
Salmeterol xinafoate. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Animals; Asthma; Bronchoconstriction; Humans; Hypersensitivity; Salmeterol Xinafoate | 1991 |
4 other study(ies) available for salmeterol xinafoate and Allergic Reaction
| Article | Year |
|---|---|
The "black box" warning and allergy drugs.
Topics: Adrenergic beta-Agonists; Albuterol; Calcineurin Inhibitors; Drug Labeling; Ethanolamines; Formoterol Fumarate; Humans; Hypersensitivity; Immunosuppressive Agents; Informed Consent; Salmeterol Xinafoate; United States; United States Food and Drug Administration | 2006 |
Systemic reaction to omalizumab.
Topics: Acetates; Adrenal Cortex Hormones; Aged; Albuterol; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis; Asthma; Cyclopropanes; Depression; Drug Hypersensitivity; Drug Therapy, Combination; Epinephrine; Female; Humans; Hypersensitivity; Hypertension; Methylprednisolone; Omalizumab; Quinolines; Rhinitis; Salmeterol Xinafoate; Seizures; Sulfides; Syncope | 2006 |
The use of newer asthma and allergy medications during pregnancy. The American College of Obstetricians and Gynecologists (ACOG) and The American College of Allergy, Asthma and Immunology (ACAAI).
Topics: Abnormalities, Drug-Induced; Acetates; Administration, Inhalation; Administration, Intranasal; Administration, Oral; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Animals; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Budesonide; Chlorpheniramine; Cyclopropanes; Ephedrine; Female; Histamine H1 Antagonists; Humans; Hydroxyurea; Hypersensitivity; Indoles; Ipratropium; Leukotriene Antagonists; Metaproterenol; Nasal Decongestants; Nebulizers and Vaporizers; Nedocromil; Phenylcarbamates; Pregnancy; Pregnancy Complications; Quinolines; Salmeterol Xinafoate; Sulfides; Sulfonamides; Terbutaline; Tosyl Compounds; Tripelennamine | 2000 |
Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung.
Topics: Adrenergic beta-Agonists; Albuterol; Histamine Release; Humans; Hypersensitivity; In Vitro Techniques; Inflammation; Lung; Mast Cells; Propranolol; Prostaglandin D2; Salmeterol Xinafoate; SRS-A | 1991 |